Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in dementia
NCT06514066Phase 3Not yet recruiting
- Sponsor
- Hospital Sultan Abdul Aziz Shah
- Start
- Sep 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
A Phase 3 trial of Zygel in Dementia, sponsored by Hospital Sultan Abdul Aziz Shah. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
Zygel
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT06514066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514066.